Catalyst Wire Dossier Catalyst Wire Dossier

Isomyosamine

Isomyosamine · TNF Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Isomyosamine, covering 2025-04-24 to 2025-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Isomyosamine in Reducing Inflammation and Treating Muscle Loss in Older Adults After Hip or Thigh Bone Fractures [Phase 2]

See pricing